ERS Genomics

ERS Genomics is a biotechnology company located in Dublin, Ireland. The company was established to enable broad access to the foundational CRISPR/Cas9 intellectual property rights held by Dr. Emmanuelle Charpentier. Non-exclusive licenses are available for research and sales of products and services across multiple fields, including: research tools, kits, and reagents; discovery of novel targets for therapeutic intervention; cell lines for discovery and screening of new drug candidates; GMP production of healthcare products; companion animal and livestock health; production of industrial materials such as enzymes, biofuels, and chemicals; and synthetic biology.